MILMED Connect Company Profile

Background

Overview

MILMED Connect is a specialized firm dedicated to bridging the gap between military medicine and technological innovation. Established in 2020, the company focuses on facilitating collaborations between MedTech, Biotech, and Pharma companies and the Department of Defense (DoD) and federal agencies. By leveraging its extensive network and expertise, MILMED Connect aims to accelerate the development and deployment of dual-use medical technologies that serve both military and civilian applications.

Mission and Vision

The mission of MILMED Connect is to design military medical (MILMED) research and development (R&D) initiatives, innovate dual-use technologies at the intersection of military and civilian medical applications, and connect stakeholders with an established network of trained MILMED R&D professionals. The vision is to enhance mission performance through innovative staffing, technology solutions, and business process management, all while maintaining a commitment to excellence and community engagement.

Primary Area of Focus

MILMED Connect specializes in military medical R&D, targeting dual-use technologies that address both military and civilian medical needs. The company provides access to an established network of MILMED R&D professionals and has pioneered processes to efficiently accelerate R&D funding and technology development.

Industry Significance

By facilitating collaborations between the private sector and federal agencies, MILMED Connect plays a crucial role in advancing medical technologies that enhance the health and readiness of military personnel while also benefiting civilian healthcare systems.

Key Strategic Focus

Core Objectives

Accelerate R&D Funding: Streamline the process for MedTech, Biotech, and Pharma companies to secure non-dilutive funding from DoD and federal agencies.

Foster Collaborations: Establish and nurture partnerships between industry leaders and military medical researchers to drive innovation.

Support Dual-Use Technologies: Promote the development of medical technologies that have applications in both military and civilian contexts.

Specific Areas of Specialization

Military Medical R&D: Design and implement research initiatives tailored to military medical needs.

Dual-Use Technology Innovation: Focus on technologies that can be utilized in both military and civilian medical settings.

Professional Network Development: Build and maintain a network of trained MILMED R&D professionals to support various projects.

Key Technologies Utilized

MILMED Connect employs advanced technologies to facilitate its operations, including:

AI-Enabled Platforms: Utilize artificial intelligence to enhance application development and invention disclosure processes.

Funding Platforms: Develop proprietary platforms to connect companies with funding opportunities and resources.

Primary Markets or Conditions Targeted

Military Healthcare: Address the unique medical needs of military personnel.

Civilian Healthcare: Develop technologies that can be adapted for civilian medical applications.

R&D Funding Landscape: Navigate the complexities of securing federal R&D funding for medical technologies.

Financials and Funding

Funding History

Specific details regarding MILMED Connect's funding history, including total funds raised and recent funding rounds, are not publicly disclosed.

Notable Investors

Information about notable investors in MILMED Connect is not publicly available.

Intended Utilization of Capital

While specific details are not disclosed, it is likely that capital is utilized to:

Expand Technological Capabilities: Enhance AI-driven platforms and other technological tools.

Support R&D Initiatives: Fund research projects and collaborations between industry and military medical researchers.

Grow Professional Network: Recruit and train additional MILMED R&D professionals to support various projects.

Pipeline Development

Key Pipeline Candidates

As a facilitator of collaborations rather than a developer of specific products, MILMED Connect does not have its own pipeline candidates. Instead, it supports the development of dual-use medical technologies by connecting companies with funding opportunities and military medical researchers.

Stages of Clinical Trials or Product Development

MILMED Connect assists companies at various stages of product development, including:

Early-Stage Research: Facilitating initial research and development efforts.

Clinical Trials: Supporting the transition from research to clinical testing.

Regulatory Approval: Guiding companies through the process of obtaining necessary approvals for military and civilian use.

Target Conditions

The technologies supported by MILMED Connect aim to address a wide range of medical conditions, including:

Traumatic Brain Injury (TBI): Developing diagnostic and therapeutic solutions.

Infectious Diseases: Creating rapid diagnostic tools and treatments.

Combat Casualties: Innovating medical solutions for battlefield injuries.

Relevant Timelines for Anticipated Milestones

Specific timelines for product development milestones vary depending on the individual projects and collaborations facilitated by MILMED Connect.

Technological Platform and Innovation

Proprietary Technologies

TECH, TEAM, TRANSITION R&D Matrix: A proprietary framework developed by MILMED Connect to guide the R&D process from concept to deployment.

MMx Funding Platform: A platform designed to connect companies with funding opportunities and resources.

Significant Scientific Methods

AI-Driven Application Development: Utilizing artificial intelligence to streamline the development of applications and invention disclosures.

Dual-Use Technology Assessment: Evaluating technologies for their applicability in both military and civilian medical contexts.

Leadership Team

Key Executives

Eric H. Hanson, MD, MPH: Co-Founder and CEO. Former Air Force physician and Division Chief of Science & Technology, specializing in connecting MedTech, Biotech, and Pharma companies with DoD and federal R&D funding.

Kirtly Raether: Co-Founder and President of R&D. Holds a Master of Biomedical Sciences from Tufts University School of Medicine and a Bachelor of Science from the University of Nevada-Las Vegas.

Competitor Profile

Market Insights and Dynamics

The market for dual-use medical technologies is growing, driven by the increasing need for innovations that can serve both military and civilian healthcare systems. This growth is supported by federal initiatives aimed at enhancing military medical capabilities and improving civilian healthcare outcomes.

Competitor Analysis

MILMED Connect operates in a niche market with few direct competitors. However, organizations such as the Medical Technology Enterprise Consortium (MTEC) also focus on advancing medical technologies for military applications. MTEC, for example, has over 650 members and collaborates on various medical technology initiatives.

Strategic Collaborations and Partnerships

MILMED Connect has established partnerships with organizations like MTEC to strengthen its position within the MILMED innovation ecosystem. These collaborations enhance the company's ability to connect stakeholders and accelerate the development of dual-use medical technologies.

Operational Insights

MILMED Connect differentiates itself through its specialized focus on dual-use medical technologies and its established network of MILMED R&D professionals. This focus allows the company to effectively navigate the complexities of military medical R&D and facilitate collaborations that might be challenging for other organizations.

Strategic Opportunities and Future Directions

Looking ahead, MILMED Connect aims to expand its network of professionals, enhance its technological platforms, and continue facilitating collaborations that lead to the development of innovative medical solutions for both military and civilian applications.